These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 9712050)
1. Aspects of antigen mimicry revealed by immunization with a peptide mimetic of Cryptococcus neoformans polysaccharide. Valadon P; Nussbaum G; Oh J; Scharff MD J Immunol; 1998 Aug; 161(4):1829-36. PubMed ID: 9712050 [TBL] [Abstract][Full Text] [Related]
2. Peptide libraries define the fine specificity of anti-polysaccharide antibodies to Cryptococcus neoformans. Valadon P; Nussbaum G; Boyd LF; Margulies DH; Scharff MD J Mol Biol; 1996 Aug; 261(1):11-22. PubMed ID: 8760499 [TBL] [Abstract][Full Text] [Related]
3. High affinity mimotope of the polysaccharide capsule of Cryptococcus neoformans identified from an evolutionary phage peptide library. Beenhouwer DO; May RJ; Valadon P; Scharff MD J Immunol; 2002 Dec; 169(12):6992-9. PubMed ID: 12471134 [TBL] [Abstract][Full Text] [Related]
4. Monoclonal antibodies reveal additional epitopes of serotype D Cryptococcus neoformans capsular glucuronoxylomannan that elicit protective antibodies. Mukherjee J; Kozel TR; Casadevall A J Immunol; 1998 Oct; 161(7):3557-68. PubMed ID: 9759877 [TBL] [Abstract][Full Text] [Related]
5. The three-dimensional structures of a polysaccharide binding antibody to Cryptococcus neoformans and its complex with a peptide from a phage display library: implications for the identification of peptide mimotopes. Young AC; Valadon P; Casadevall A; Scharff MD; Sacchettini JC J Mol Biol; 1997 Dec; 274(4):622-34. PubMed ID: 9417940 [TBL] [Abstract][Full Text] [Related]
6. Analysis of human monoclonal antibodies elicited by vaccination with a Cryptococcus neoformans glucuronoxylomannan capsular polysaccharide vaccine. Pirofski L; Lui R; DeShaw M; Kressel AB; Zhong Z Infect Immun; 1995 Aug; 63(8):3005-14. PubMed ID: 7622223 [TBL] [Abstract][Full Text] [Related]
7. Unexpected diversity in the fine specificity of monoclonal antibodies that use the same V region gene to glucuronoxylomannan of Cryptococcus neoformans. McFadden DC; Casadevall A J Immunol; 2004 Mar; 172(6):3670-7. PubMed ID: 15004170 [TBL] [Abstract][Full Text] [Related]
8. Synthesis and immunological studies of glycoconjugates of Cryptococcus neoformans capsular glucuronoxylomannan oligosaccharide structures. Oscarson S; Alpe M; Svahnberg P; Nakouzi A; Casadevall A Vaccine; 2005 Jun; 23(30):3961-72. PubMed ID: 15917118 [TBL] [Abstract][Full Text] [Related]
9. Molecular and idiotypic analyses of the antibody response to Cryptococcus neoformans glucuronoxylomannan-protein conjugate vaccine in autoimmune and nonautoimmune mice. Nussbaum G; Anandasabapathy S; Mukherjee J; Fan M; Casadevall A; Scharff MD Infect Immun; 1999 Sep; 67(9):4469-76. PubMed ID: 10456888 [TBL] [Abstract][Full Text] [Related]
10. Molecular and idiotypic analysis of antibodies to Cryptococcus neoformans glucuronoxylomannan. Casadevall A; DeShaw M; Fan M; Dromer F; Kozel TR; Pirofski LA Infect Immun; 1994 Sep; 62(9):3864-72. PubMed ID: 8063403 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of immune sera from human immunoglobulin transgenic mice immunized with a peptide mimotope of Cryptococcus neoformans glucuronoxylomannan. Maitta RW; Datta K; Pirofski LA Vaccine; 2004 Sep; 22(29-30):4062-8. PubMed ID: 15364457 [TBL] [Abstract][Full Text] [Related]
12. A cryptococcal capsular polysaccharide mimotope prolongs the survival of mice with Cryptococcus neoformans infection. Fleuridor R; Lees A; Pirofski L J Immunol; 2001 Jan; 166(2):1087-96. PubMed ID: 11145689 [TBL] [Abstract][Full Text] [Related]
13. Molecular basis for immunoglobulin M specificity to epitopes in Cryptococcus neoformans polysaccharide that elicit protective and nonprotective antibodies. Nakouzi A; Valadon P; Nosanchuk J; Green N; Casadevall A Infect Immun; 2001 May; 69(5):3398-409. PubMed ID: 11292763 [TBL] [Abstract][Full Text] [Related]
14. Protective and nonprotective human immunoglobulin M monoclonal antibodies to Cryptococcus neoformans glucuronoxylomannan manifest different specificities and gene use profiles. Maitta RW; Datta K; Chang Q; Luo RX; Witover B; Subramaniam K; Pirofski LA Infect Immun; 2004 Aug; 72(8):4810-8. PubMed ID: 15271943 [TBL] [Abstract][Full Text] [Related]
15. Two different methods result in the selection of peptides that induce a protective antibody response to Neisseria meningitidis serogroup C. Prinz DM; Smithson SL; Westerink MA J Immunol Methods; 2004 Feb; 285(1):1-14. PubMed ID: 14871530 [TBL] [Abstract][Full Text] [Related]
16. Anti-glucuronoxylomannan IgG1 specific antibodies production in Cryptococcus neoformans resistant mice. Parra C; González JM; Castañeda E; Fiorentino S Biomedica; 2005 Mar; 25(1):110-9. PubMed ID: 15962907 [TBL] [Abstract][Full Text] [Related]
17. Antibodies to keyhole limpet hemocyanin cross-react with an epitope on the polysaccharide capsule of Cryptococcus neoformans and other carbohydrates: implications for vaccine development. May RJ; Beenhouwer DO; Scharff MD J Immunol; 2003 Nov; 171(9):4905-12. PubMed ID: 14568972 [TBL] [Abstract][Full Text] [Related]
18. [Monoclonal antibodies recognizing the capsular polysaccharide of Cryptococcus neoformans]. Rodríguez Sánchez H; Pupo Antúnez M; Ilnait MT; Otero A; Martínez Machín G Rev Cubana Med Trop; 2005; 57(2):162-4. PubMed ID: 17966590 [TBL] [Abstract][Full Text] [Related]
19. Peptide mimics of two pneumococcal capsular polysaccharide serotypes (6B and 9V) protect mice from a lethal challenge with Streptococcus pneumoniae. Smith CM; Lo Passo C; Scuderi A; Kolberg J; Baxendale H; Goldblatt D; Oggioni MR; Felici F; Andrew PW Eur J Immunol; 2009 Jun; 39(6):1527-35. PubMed ID: 19499518 [TBL] [Abstract][Full Text] [Related]
20. Peptide epitopes recognized by a human anti-cryptococcal glucuronoxylomannan antibody. Zhang H; Zhong Z; Pirofski LA Infect Immun; 1997 Apr; 65(4):1158-64. PubMed ID: 9119446 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]